DOXYCYCLINE MONOHYDRATE vs TIGECYCLINE

Compare DOXYCYCLINE MONOHYDRATE (Doxycycline Monohydrate) and TIGECYCLINE (Tigecycline) — clinical data, side effects, and patient experiences.

DOXYCYCLINE MONOHYDRATE

Doxycycline Monohydrate, Vibramycin, Efracea · Tetracycline Antibiotic

How it works

Tetracycline Antibiotic agent

Approved for

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules and other antibacterial drugs

they should be considered in selecting or modifying antibacterial therapy. In the absence of such data

local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections: Rocky mountain spotted fever

typhus fever and the typhus group

OralTablet

TIGECYCLINE

Tigecycline · Tetracycline Antibiotic

How it works

12.1 Mechanism of Action Tigecycline is a tetracycline class antibacterial [see Microbiology ( 12.4 )] .

Approved for

including ventilator-associated pneumonia ( 1.4 ). To reduce the development of drug-resistant bacteria and maintain the effectiveness of tigecycline for injection and other antibacterial drugs

Enterococcus faecalis (vancomycin-susceptible isolates)

Staphylococcus aureus (methicillin-susceptible and -resistant isolates)

Streptococcus agalactiae

IntravenousTablet

Quick Comparison

DOXYCYCLINE MONOHYDRATETIGECYCLINE

Drug Class

Tetracycline Antibiotic

Route

Oral

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

DOXYCYCLINE MONOHYDRATE

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Rash

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Vomiting

1-10%

TIGECYCLINE

Drug Not Working

>10%

Nausea

1-10%

Vomiting

1-10%

Diarrhea

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

DOXYCYCLINE MONOHYDRATE

WARNINGS The use of drugs of the tetracycline class, including doxycycline, during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown)
Use of doxycycline in pediatric patients 8 years of age or less only when the potential benefits are expected to outweigh the risks in severe or life-threatening conditions (e
Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including doxycycline capsules, and may range in severity from mild diarrhea to fatal colitis
Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH

TIGECYCLINE

5 WARNINGS AND PRECAUTIONS All-Cause Mortality: A meta-analysis of Phase 3 and 4 clinical trials demonstrated an increase in all-cause mortality in tigecycline-treated patients compared to controls with a risk difference of 0
Patients who develop abnormal liver function tests during tigecycline for injection therapy should be monitored for evidence of worsening hepatic function and evaluated for risk/benefit of continuing tigecycline therapy
4 ) Pancreatitis: including fatalities, has been reported with tigecycline for injection
In all 13 Phase 3 and 4 trials that included a comparator, death occurred in 4% (150/3,788) of patients receiving tigecycline for injection and 3% (110/3,646) of patients receiving comparator drugs

Clinical Trial Data

No head-to-head clinical studies found for DOXYCYCLINE MONOHYDRATE vs TIGECYCLINE.

DOXYCYCLINE MONOHYDRATE vs TIGECYCLINE: What You Should Know

Key Differences

Both DOXYCYCLINE MONOHYDRATE and TIGECYCLINE belong to the Tetracycline Antibiotic class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. DOXYCYCLINE MONOHYDRATE is administered via Oral, whereas TIGECYCLINE uses Intravenous. Route of administration can affect onset of action and patient adherence.

Safety Considerations

DOXYCYCLINE MONOHYDRATE carries 4 FDA warnings. TIGECYCLINE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

DOXYCYCLINE MONOHYDRATE vs OMADACYCLINE→OMADACYCLINE vs TIGECYCLINE→DOXYCYCLINE MONOHYDRATE vs TETRACYCLINE HYDROCHLORIDE→DOXYCYCLINE vs DOXYCYCLINE MONOHYDRATE→DOXYCYCLINE HYCLATE vs DOXYCYCLINE MONOHYDRATE→DOXYCYCLINE MONOHYDRATE vs MINOCYCLINE HYDROCHLORIDE→

Loading comparison data...

DOXYCYCLINE MONOHYDRATE vs TIGECYCLINE

Compare DOXYCYCLINE MONOHYDRATE (Doxycycline Monohydrate) and TIGECYCLINE (Tigecycline) — clinical data, side effects, and patient experiences.

DOXYCYCLINE MONOHYDRATE

Doxycycline Monohydrate, Vibramycin, Efracea · Tetracycline Antibiotic

How it works

Tetracycline Antibiotic agent

Approved for

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules and other antibacterial drugs

they should be considered in selecting or modifying antibacterial therapy. In the absence of such data

local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections: Rocky mountain spotted fever

typhus fever and the typhus group

OralTablet

TIGECYCLINE

Tigecycline · Tetracycline Antibiotic

How it works

12.1 Mechanism of Action Tigecycline is a tetracycline class antibacterial [see Microbiology ( 12.4 )] .

Approved for

including ventilator-associated pneumonia ( 1.4 ). To reduce the development of drug-resistant bacteria and maintain the effectiveness of tigecycline for injection and other antibacterial drugs

Enterococcus faecalis (vancomycin-susceptible isolates)

Staphylococcus aureus (methicillin-susceptible and -resistant isolates)

Streptococcus agalactiae

IntravenousTablet

Quick Comparison

DOXYCYCLINE MONOHYDRATETIGECYCLINE

Drug Class

Tetracycline Antibiotic

Route

Oral

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

DOXYCYCLINE MONOHYDRATE

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Rash

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Vomiting

1-10%

TIGECYCLINE

Drug Not Working

>10%

Nausea

1-10%

Vomiting

1-10%

Diarrhea

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

DOXYCYCLINE MONOHYDRATE

WARNINGS The use of drugs of the tetracycline class, including doxycycline, during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown)
Use of doxycycline in pediatric patients 8 years of age or less only when the potential benefits are expected to outweigh the risks in severe or life-threatening conditions (e
Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including doxycycline capsules, and may range in severity from mild diarrhea to fatal colitis
Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH

TIGECYCLINE

5 WARNINGS AND PRECAUTIONS All-Cause Mortality: A meta-analysis of Phase 3 and 4 clinical trials demonstrated an increase in all-cause mortality in tigecycline-treated patients compared to controls with a risk difference of 0
Patients who develop abnormal liver function tests during tigecycline for injection therapy should be monitored for evidence of worsening hepatic function and evaluated for risk/benefit of continuing tigecycline therapy
4 ) Pancreatitis: including fatalities, has been reported with tigecycline for injection
In all 13 Phase 3 and 4 trials that included a comparator, death occurred in 4% (150/3,788) of patients receiving tigecycline for injection and 3% (110/3,646) of patients receiving comparator drugs

Clinical Trial Data

No head-to-head clinical studies found for DOXYCYCLINE MONOHYDRATE vs TIGECYCLINE.

DOXYCYCLINE MONOHYDRATE vs TIGECYCLINE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.